Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria K Magnusson

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Gastroenterology|January 20, 2016
Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's diseaseAnders Dige, Maria K Magnusson, Lena Öhman, et al.
Scientific Reports|April 22, 2021
Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitisLena Öhman, Anders Lasson, Anna Strömbeck, et al.
Journal of Virology|June 15, 2004
Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cellsFlorence Gaden, Laure Franqueville, Maria K Magnusson, et al.
BMC Gastroenterology|May 6, 2020
Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's diseaseAnna Strömbeck, Anders Lasson, Hans Strid, et al.
Helicobacter|September 11, 2019
The frequency of circulating integrin α4β7<sup>+</sup> cells correlates with protection against Helicobacter pylori infection in immunized miceSarmin Akter, Frida Jeverstam, Anna Lundgren, et al.
Mediators of Inflammation|June 2, 2018
Effects of Anti-TNF<i>α</i> Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn's DiseaseAnders Dige, Maria K Magnusson, Claus Uhrenholt, et al.
Neurogastroenterology and Motility|April 29, 2022
Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoidsCristina Iribarren, Sofia Nordlander, Johanna Sundin, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 14, 2021
Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During RemissionLujain Maasfeh, Anetta Härtlova, Stefan Isaksson, et al.
Neurogastroenterology and Motility|April 22, 2020
Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndromeBani Ahluwalia, Maria K Magnusson, Lena Böhn, et al.
United European Gastroenterology Journal|June 12, 2014
CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitisMaria K Magnusson, Rahil Dahlén, Hans Strid, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Gastroenterology|January 20, 2016
Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's diseaseAnders Dige, Maria K Magnusson, Lena Öhman, et al.
Scientific Reports|April 22, 2021
Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitisLena Öhman, Anders Lasson, Anna Strömbeck, et al.
Journal of Virology|June 15, 2004
Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cellsFlorence Gaden, Laure Franqueville, Maria K Magnusson, et al.
BMC Gastroenterology|May 6, 2020
Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's diseaseAnna Strömbeck, Anders Lasson, Hans Strid, et al.
Helicobacter|September 11, 2019
The frequency of circulating integrin α4β7<sup>+</sup> cells correlates with protection against Helicobacter pylori infection in immunized miceSarmin Akter, Frida Jeverstam, Anna Lundgren, et al.
Mediators of Inflammation|June 2, 2018
Effects of Anti-TNF<i>α</i> Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn's DiseaseAnders Dige, Maria K Magnusson, Claus Uhrenholt, et al.
Neurogastroenterology and Motility|April 29, 2022
Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoidsCristina Iribarren, Sofia Nordlander, Johanna Sundin, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 14, 2021
Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During RemissionLujain Maasfeh, Anetta Härtlova, Stefan Isaksson, et al.
Neurogastroenterology and Motility|April 22, 2020
Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndromeBani Ahluwalia, Maria K Magnusson, Lena Böhn, et al.
United European Gastroenterology Journal|June 12, 2014
CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitisMaria K Magnusson, Rahil Dahlén, Hans Strid, et al.
Pageof 6